Bayesian Study Designs in Early-Phase Oncology Trials
The development of innovative oncology therapies has evolved dramatically, moving beyond...
Posts about
Oncology (2)
Biostatisticians: Ensuring the validity, reliability, and interpretability of clinical trial data
Discussion with Erin Mathias, Sr. Director, Global Biostatistics
Cancer Research Trends | Key ASCO 2024 Takeaways
Discussion with Gabriela Rosu, MD, Sr. Director, Global Medical Affairs
Positioning a Sponsor’s First Trial for Success: A Comprehensive Planning Approach for Cancer Antibody
Clinical trials require meticulous planning and strategic guidance for success. In this case study,...
Successful Full-Service, Randomized Pancreatic Cancer Phase II Trial
Learn how Veristat’s multidisciplinary team was able to work with the sponsor to solve challenges...
Understanding FDA's Project Optimus
Project Optimus is an initiative from the FDA Oncology Center of Excellence led by Drs. Mirat Shah...
Planning the Way Forward for a New Tumor Evaluation Modality
RECIST (Response Evaluation Criteria in Solid Tumors) guidelines were introduced over twenty years...
Is it Possible to Gain Regulatory Approval Following a Single-Arm Study?
In this case study example - yes.
Veristat developed a thorough regulatory submission strategy and...